Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2023/05/24/biotech-stock-drops-on-fda-update

5/24/2023 10:53 AM

Sarepta Therapeutics Inc (NASDAQ:SRPT) is gaining some attention in the biotech realm today. The company is seeking accelerated approval from the U.S. Food & Drug Administration (FDA) for its gene the...

Serepta Stock Nearly Halves After Failed Gene Therapy Study

https://www.schaeffersresearch.com/content/news/2021/01/08/serepta-stock-nearly-halves-after-failed-gene-therapy-study

1/8/2021 10:07 AM

The shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) have nearly halved this morning, down 49.8% at $84.90 at last check, after the company's experimental gene therapy to treat Duchene muscular dystr...

Stocks Eye Holiday Week Gains

https://www.schaeffersresearch.com/content/ezines/2019/12/23/stocks-eye-holiday-week-gains

12/23/2019 9:11 AM

Fresh off a record-setting week, Dow Jones Industrial Average (DJI) futures are trending higher yet again. Fueling this morning's risk-on approach are trade tailwinds out of China, after the countr...

Wave Life Sciences Stock Folds on Drug Decision

https://www.schaeffersresearch.com/content/options/2019/12/16/wave-life-sciences-stock-folds-on-drug-decision

12/16/2019 2:37 PM

The shares of pharmaceutical concern Wave Life Sciences Ltd (NASDAQ:WVE) have more than halved today after the firm said it would be halting the development of its Duchenne muscular distrophy (DMD) d...

Sarepta Therapeutics Stock Eyes Best Day in 3 Years on FDA Reversal

https://www.schaeffersresearch.com/content/news/2019/12/13/sarepta-therapeutics-stock-eyes-best-day-in-3-years-on-fda-reversal

12/13/2019 11:31 AM

Drug maker Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring this morning, up 33% at $132.50. The company's Duchenne Muscular Dystrophy (DMD) treatment was approved by the Food and Drug Administration...

PEOPLE ALSO SEARCH FOR